Sign in

APHA on NYSE

Aphria

Canadian cannabis company

Aphria Inc., headquartered in Leamington, Ontario, was an international producer and distributor of medicinal and recreational cannabis. The company operated through retail and wholesale channels in Canada and internationally. Aphria was a main distributor of medical cannabis to Germany and had operations in 10 additional countries outside of Canada.3 Its revenue was C$36.9 million in 2018.1 Its shares trade on NYSE under the symbol APHA.1 It ceased to exist in 2021.1 Wikipedia text CC BY-SA 4.0

Price unavailable

Last updated Oct 21, 2026.

Overview

2014Founded1

Compare with another stock.

  • TickerAPHA on NYSE1
  • Industrycannabis industry1
  • HeadquartersLeamington1
  • Websiteaphria.com
  • Legal formbusiness corporation1
  • Listed onNew York Stock Exchange (APHA), Toronto Stock Exchange (APHA)1
  • LEI52990092S6BM5E48CI114
  • StatusActive4
  • LEI statusLapsed (not renewed)4
  • Registered address245 Talbot, St. W., Suite 103, N8H 1N8 Leamington, Canada4

See how the biggest companies compare on our leaderboards

Aphria Inc., headquartered in Leamington, Ontario, was an international producer and distributor of medicinal and recreational cannabis. The company operated through retail and wholesale channels in Canada and internationally.3

What it owns

What Aphria reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, net587.2M CAD6 May 31, 2020503.9M CAD6 May 31, 2019+16.5%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents497.2M CAD6 May 31, 2020550.8M CAD6 May 31, 2019−9.7%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill617.9M CAD6 May 31, 2020669.8M CAD6 May 31, 2019−7.7%
Intangible assets, net (excluding goodwill)363.0M CAD6 May 31, 2020392.1M CAD6 May 31, 2019−7.4%

Inventory

ItemLatestA year beforeChange
Inventory, total264.3M CAD6 May 31, 202091.5M CAD6 May 31, 2019+188.8%

The story

Aphria was founded in 2013 by Cole Cacciavillani and John Cervini, who were Leamington greenhouse operators. Its CEO for its formative years was Vic Neufeld, formerly the CEO of Jamieson Laboratories, a Canadian vitamin company. It was originally listed on the Toronto Venture Exchange before it was uplisted to the Toronto Stock Exchange in March of 2017, and joined the S&P/TSX Composite Index in December 2017.

In 2014, Health Canada granted Aphria a license to produce and sell medical cannabis. The company's first wholesale shipments were in April 2015. Also in April 2015, the company announced it would double the size of its greenhouse space.

In January 2018, Aphria agreed to take over Broken Coast Cannabis, a Vancouver Island based cannabis producer. In March the same year, the company acquired Nuuvera, a global cannabis company, for CA$826 million. In May 2018, Aphria reached a deal with Southern Glazer's Wine & Spirits to distribute Aphria's recreational cannabis products in Canada.

Aphria nominated Irwin D. Simon, previously of The Hain Celestial Group, Inc., as Chair of the Board of Directors in December 2018 and interim CEO in March 2019 after former CEO Vic Neufeld resigned.

In 2020, the company moved its listing from the New York Stock Exchange to the NASDAQ, citing cost cuts as the reason for the change.

From Wikipedia’s article on Aphria Inc., shared under CC BY-SA 4.0.5

Products and brands

  • cannabis
  • medical cannabis

Listed on Wikidata.1

Acquisitions

On 15 December 2020, Aphria conducted a reverse acquisition to merge with Tilray, which would create the largest multinational cannabis company by revenue. CEO of Aphria was named as CEO and chairman of the board for the merged company and Tilray CEO Brendan Kennedy, was named as a member of the board of directors.

The merged companies kept Tilray's name and trade under the Tilray ticker symbol, TLRY, on the NASDAQ exchange. By combining assets, the Aphria-Tilray company develops craft beer and cannabis-infused beverages in partnership with Anheuser-Busch InBev, and have branded hemp and cannabidiol products. The merger was completed in May 2021.

From Wikipedia’s article on Aphria Inc., shared under CC BY-SA 4.0.5

Revenue over time

As stated on Wikidata, in the currency reported.

Revenue

  • 201836.9M CAD1

Timeline

  1. 2021Dissolved Dissolved1
  2. 2014Founded Founded1

Members of Congress who traded it

2 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.

DateMemberTradeAmountVs S&P sinceFiling
Feb 18, 2021Brian J. MastRepublican, HouseBuy$15,001 - $50,000Report
Nov 5, 2020John A. Yarmuth, HouseBuy$1,001 - $15,000Report

Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).

SEC filer profile

How Aphria is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARAphria Inc.2
  • CIK0001733418
  • Filer status<br>emerging growth company2
  • Incorporated inAlberta, Canada2
  • Fiscal year endsMay 312
  • Industry code (SIC)2833 Medicinal Chemicals & Botanical Products2
  • Business address245 Talbot Street W., Suite 103, Leamington, A6 N8H 1N82
  • Phone(844) 427-47422
  • Shares outstanding286,520,265 as of May 31, 20206
  • On EDGAR sinceMar 5, 20182
  • Filings175 in all: 6-K (131), 425 (7), F-X (4), SC14D1F/A (4), SUPPL (3), 40-F (2), CERT (2), EFFECT (2)2
    All 26 form types

    F-10 (2), F-10/A (2), 15-12B (1), 25 (1), 25-NSE (1), 40-F/A (1), 40FR12B (1), 8-A12B (1), DEL AM (1), F-10POS (1), F-3 (1), RW (1), S-3ASR (1), SC 13G (1), SC 14D9 (1), SC14D1F (1), SC14D9F (1), UPLOAD (1)

  • Latest filingsAnnual report (40-F) Jul 29, 2020

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6